NIH Prize Links Liberal Arts and Brain Trauma

One doesn’t usually connect liberal arts graduate students with neuroscience research, but now Penn has.

Two Master of Liberal Arts students from Penn’s College of Liberal and Professional Studies were winners in the National Institute of Health’s (NIH) Neuro Startup Challenge. The NIH developed the challenge to attract students to create launch campaigns for its unlicensed technologies, all of which treat brain-related illnesses.

Krystle Karoscik and Medha Sengupta, who will earn their Penn graduate degrees in August, are now working to market a device that simulates a blast-induced traumatic brain injury (TBI), offering hope for the future diagnosis and treatment of TBIs. This new technology is unique because of its ability to examine and record—on a cellular level—what occurs when brain cells are exposed to a blast from an explosive device.

Because the device allows them to adjust and record a blast’s effect in real time, they can track and compare any cellular changes. “It is very difficult to diagnose a TBI,” Karoscik says. “Without a proper diagnosis, it is challenging to provide an effective treatment to the injured individual.” Sengupta adds, “Because we’re able to record what’s happening on a cellular level, we will have more data to share with the physicians treating TBI patients.”

The two entrepreneurs met in January 2013 while working at the Clinical Cell and Vaccine Production Facility at Penn Medicine and began their Master of Liberal Arts programs in 2014. Karoscik’s concentration is neurosciences and bioethics. She currently works at The Children’s Hospital of Philadelphia as a project manager in the Department of Neurology and oversees the initiation and maintenance of research studies for pediatric demyelinating diseases. She plans to apply to Penn to earn her Ph.D., matriculating in 2016. Sengupta’s concentration is in neurobiology and public health. She works at Penn’s School of Medicine as a clinical coordinator, overseeing the quality assurance of clinical trials for cancer. They have named their company Amavii, which comes from the Italian and Latin words for love and compassion. They are working to incorporate the business and apply for licensing.

Click here Neuro Startup Challenge to learn more about the Neuro Startup Challenge.

Arts & Sciences News

Marlyse Baptista Named President’s Distinguished Professor of Linguistics

Baptista directs the Language Contact and Cognition Lab in the Department of Linguistics and is a faculty member in MindCORE.

View Article >
Andrew Zahrt Receives Scialog Funding for Automating Chemical Laboratories

Scialog: Automating Chemical Laboratories aims to accelerate innovation and broaden access within the chemical enterprise through advances in automated instrumentation and artificial intelligence.

View Article >
Chatelain, Mani, Marteleto, and Mattern Named Presidential Penn Compact Professors

The professors are conducting innovative research in Africana Studies, English, Sociology, and Cinema & Media Studies.

View Article >
Simon Richter Named Class of 1965 Term Professor of German

An environmental humanist, Richter’s research focuses on cultural aspects of the climate emergency in Germany, Indonesia, the Netherlands, and the United States.

View Article >
Peter Struck Named Stephen A. Levin Family Dean of the College of Arts & Sciences

Struck, a distinguished classicist, award-winning teacher, and innovative program leader, starts the new appointment on Aug. 1, 2024.

View Article >
Ala Stanford, National Leader in Health Equity, Joins Penn

Stanford is now a Professor of Practice in the School of Arts & Sciences Department of Biology, with additional appointments in the Penn Institute for RNA Innovation and Annenberg School for Communication.

View Article >